Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Potassium Chloride

From Pharmacopedia
Revision as of 03:34, 23 May 2026 by MDElliottMD (talk | contribs) (parser-claude batch MedTemplate pre-fill, Top 300 #44)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Potassium chloride
K-Dur, Klor-Con, Slow-K, Micro-K, K-Lyte/Cl

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Pharmacy
Starting dose
10-20 mEq PO daily for prevention; treat established hypokalemia per measured deficit, typically 40-100 mEq/d in divided doses; IV 10 mEq/h peripheral, 20 mEq/h central with telemetry
Preparations
8, 10, 20, 25 mEq tablets/capsules (most ER); effervescent and oral solution; IV concentrate (must be diluted)
US FDA Max
IV peripheral 10 mEq/h (40 mEq/L); IV central 20 mEq/h with cardiac monitoring; PO single doses generally ≤40 mEq
Pharmacology
Routes
Oral, IV
Onset
Hours (PO); IV faster but rate-limited
Duration
Variable; depends on ongoing losses
Half-life
Not meaningfully described for an electrolyte; distribution between intra- and extracellular compartments is the relevant kinetic
Bioavailability
60-80% (oral)
Pregnancy
Generally safe at replacement doses; treat the underlying cause of hypokalemia.[citation needed]
Legal status
Rx-only (higher concentrations and IV) and OTC (low-dose supplements) in US
Purported mechanism
Oral and intravenous potassium chloride replenish extracellular and total-body potassium; the chloride salt is preferred in metabolic alkalosis because it simultaneously addresses the typical co-existing chloride and volume deficit.0 Total body potassium is ~98% intracellular, so plasma K+ is a delayed and imperfect surrogate for whole-body status; magnesium repletion is often required for hypokalemia to correct. Rapid IV administration without dilution is a recognized cause of fatal arrhythmia and one of the most well-known medication-error patterns in hospital pharmacy[1].

References

  1. FDA Prescribing Information, potassium chloride extended-release tablets, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018834s029,019402s022,019819s022lbl.pdf